HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Heine Selected Research

queuine tRNA-ribosyltransferase

1/202219F-NMR Unveils the Ligand-Induced Conformation of a Catalytically Inactive Twisted Homodimer of tRNA-Guanine Transglycosylase.
10/2021Unraveling a Ligand-Induced Twist of a Homodimeric Enzyme by Pulsed Electron-Electron Double Resonance.
1/2021Targeting a Cryptic Pocket in a Protein-Protein Contact by Disulfide-Induced Rupture of a Homodimeric Interface.
1/2018Swapping Interface Contacts in the Homodimeric tRNA-Guanine Transglycosylase: An Option for Functional Regulation.
1/2017Soaking suggests "alternative facts": Only co-crystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition.
1/2015Replacement of water molecules in a phosphate binding site by furanoside-appended lin-benzoguanine ligands of tRNA-guanine transglycosylase (TGT).
9/2013High-affinity inhibitors of Zymomonas mobilis tRNA-guanine transglycosylase through convergent optimization.
12/2009How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase.
3/2009Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Heine Research Topics

Disease

11Bacillary Dysentery (Shigellosis)
01/2022 - 03/2009
3Foodborne Diseases
01/2015 - 07/2012
2Multiple Sclerosis
01/2022 - 01/2018
2Rupture
01/2021 - 10/2006
2Diabetes Complications
01/2017 - 05/2007
1Breast Neoplasms (Breast Cancer)
01/2022
1Hemorrhage
01/2020
1Phenylketonurias (Phenylketonuria)
01/2018
1Osteoarthritis
01/2016
1Dysentery
07/2007
1Infections
07/2007
1Glaucoma
01/2004
1Neoplasms (Cancer)
09/2003

Drug/Important Bio-Agent (IBA)

10EnzymesIBA
01/2022 - 07/2007
9queuine tRNA-ribosyltransferaseIBA
01/2022 - 03/2009
3LigandsIBA
10/2021 - 10/2006
2Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2009
2Transfer RNA (tRNA)IBA
01/2018 - 09/2013
2Aldehyde Reductase (Aldose Reductase)IBA
01/2017 - 05/2007
2Pharmaceutical PreparationsIBA
01/2015 - 09/2013
1DisulfidesIBA
01/2021
1AnticoagulantsIBA
01/2020
1Factor XIII (Coagulation Factor XIII)IBA
01/2020
1ThrombinFDA Link
01/2020
1sapropterin (tetrahydrobiopterin)FDA Link
01/2018
1Serine Proteases (Serine Protease)IBA
01/2016
1matriptaseIBA
01/2016
1Shiga Toxin (Shigella Toxin)IBA
07/2012
1Glucose (Dextrose)FDA LinkGeneric
05/2007
1polyolIBA
05/2007
1Peptides (Polypeptides)IBA
10/2006
1zopolrestatIBA
10/2006
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2004
1PeptidomimeticsIBA
09/2003
1Integrin alphaVbeta3IBA
09/2003

Therapy/Procedure

4Therapeutics
01/2022 - 09/2003
2Drug Therapy (Chemotherapy)
11/2020 - 01/2017
1Immunotherapy
09/2003